azafol
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2017 (NCT03242993)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06335888 | Phase 2 | Jun 30, 2024 | Paul Scherrer Institute, Villigen, Switzerland, University of Bern |
| NCT03242993 | Phase 1 | Apr 1, 2017 | Cantonal Hospital of St. Gallen, University of Lausanne, University of Zurich |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Paul Scherrer Institute, Villigen, Switzerland | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Bern | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Lausanne | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Zurich | Academic/Hospital | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1